Mind the Gap: Stop Selling Efficacy When the Market Needs Scale
Category: Commercial Strategy | Market Intelligence | Data Architecture
The Diagnosis
The advanced therapies sector is saturated with messaging focused on novelty and clinical efficacy. When marketing enabling technologies or CDMO services to therapy developers, it is a common reflex to lead with scientific breakthroughs. However, our raw Voice of Customer (VOC) data reveals a significant misalignment between what tech vendors are selling and what therapy developers are actively seeking.
By deploying AI to analyze unstructured text (Natural Language Processing) across 3,500+ technology platforms in the CGT space, we identified a clear operational mandate. Developers are primarily seeking foundational operational solutions: cost-effective scalability.
Specifically, Cost/Financial constraints (42%) and Scalability/Manufacturing processes (42%) were the overwhelmingly dominant pain points, accounting for 84% of the top concerns. This far outpaces concerns over clinical efficacy, which represented just 15%. If a commercial value proposition does not directly address Cost of Goods Sold (COGS) and manufacturing scale, it fundamentally misaligns with the developers' immediate strategic priorities.
The Solution
To close this commercial gap, service providers must transition from generic, efficacy-led marketing to highly targeted, scale-led business development.
This requires architecting BD enablement tools that integrate live VOC data and financial burn-rate models directly into commercial workflows. By equipping sales teams with tools that automatically calculate the precise ROI of a technology based on a prospect's current financial runway and scaling parameters, providers can shift the conversation from Our technology works to Our technology extends your runway by 8 months.
The Lab Insight
During the development of VantagePoint™ internal scoring engines, we consistently observed that technology solutions focusing purely on efficacy often stalled in BD pipelines. The breakthrough occurred when we integrated COGS reduction and throughput metrics directly into the lead scoring algorithm. Prospects engaged significantly faster when the technical solution was presented as a direct mitigant to their burn rate.
Adjust the automation slider in our VantagePoint™ Manufacturing Cost Modeler below to see the direct correlation between automated workflows and reduced cash burn. To explore how these models can integrate with your BD strategy, contact Lonrú Consulting.
Want to prove exactly how much your platform reduces COGS and extends financial runway? Let's build your custom VantagePoint™ ROI dashboard.
